Full Version - English
This presentation is a review of the most important changes to the WHO hematopathology classification system as part of the 2016 revision. Emphasis will be placed on presenting the information so that it is relevant and understandable by non-hematopathologists and laboratory staff. This will be a two-part presentation, with the first lecture covering lymphoid neoplasms and the second presentation covering myeloid and precursor neoplasms. November 17, 2016 is the part two of the series.
- Understand the need for the 2016 revision to the 2008 WHO hematopathology classification system.
- Review pertinent changes involving lymphoid neoplasms in a manner understandable by general pathologists and laboratory staff.
- Illustrate important situations where advanced testing (e.g. IHC, molecular, FISH) may be helpful in further distinguishing hematopoietic neoplasms, which had been difficult to classify or confirm with certainty in the past.